42 related articles for article (PubMed ID: 22781794)
1. [Enrichment analysis of Fanconi anemia gene expression profiles in cancer related genesets].
Zhou QQ; Wang XJ; Zhu XF; Yuan WP; Cheng T
Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):371-7. PubMed ID: 22781794
[TBL] [Abstract][Full Text] [Related]
2. Lowered expression levels of a tumor suppressor gene - caveolin-1 within dysregulated gene networks of Fanconi anemia.
Shyamsunder P; Vidyasekar P; Shukla AR; Mohan S; Verma RS
Gene; 2013 Sep; 527(2):521-8. PubMed ID: 23845778
[TBL] [Abstract][Full Text] [Related]
3. Relationship of insulin-like growth factors system gene polymorphisms with the susceptibility and pathological development of hepatocellular carcinoma.
Weng CJ; Hsieh YH; Tsai CM; Chu YH; Ueng KC; Liu YF; Yeh YH; Su SC; Chen YC; Chen MK; Yang SF
Ann Surg Oncol; 2010 Jul; 17(7):1808-15. PubMed ID: 20119675
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow cell transcripts from Fanconi anaemia patients reveal in vivo alterations in mitochondrial, redox and DNA repair pathways.
Pagano G; Talamanca AA; Castello G; d'Ischia M; Pallardó FV; Petrović S; Porto B; Tiano L; Zatterale A
Eur J Haematol; 2013 Aug; 91(2):141-51. PubMed ID: 23646927
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of fibroblast growth factors on expression of genes of the plasminogen activator and insulin-like growth factor systems by human breast fibroblasts.
Sieuwerts AM; Martens JW; Dorssers LC; Klijn JG; Foekens JA
Thromb Haemost; 2002 Apr; 87(4):674-83. PubMed ID: 12008951
[TBL] [Abstract][Full Text] [Related]
7. Fanconi anemia pathway--the way of DNA interstrand cross-link repair.
Yao CJ; Du W; Zhang Q; Zhang F; Zeng F; Chen FP
Pharmazie; 2013 Jan; 68(1):5-11. PubMed ID: 23444773
[TBL] [Abstract][Full Text] [Related]
8. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
[TBL] [Abstract][Full Text] [Related]
9. Coinheritance of BRCA1 and BRCA2 mutations with Fanconi anemia and Bloom syndrome mutations in Ashkenazi Jewish population: possible role in risk modification for cancer development.
Koren-Michowitz M; Friedman E; Gershoni-Baruch R; Brok-Simoni F; Patael Y; Rechavi G; Amariglio N
Am J Hematol; 2005 Mar; 78(3):203-6. PubMed ID: 15726604
[TBL] [Abstract][Full Text] [Related]
10. Chemosensitizing tumor cells by targeting the Fanconi anemia pathway with an adenovirus overexpressing dominant-negative FANCA.
Ferrer M; de Winter JP; Mastenbroek DC; Curiel DT; Gerritsen WR; Giaccone G; Kruyt FA
Cancer Gene Ther; 2004 Aug; 11(8):539-46. PubMed ID: 15192709
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector.
Walsh CE; Nienhuis AW; Samulski RJ; Brown MG; Miller JL; Young NS; Liu JM
J Clin Invest; 1994 Oct; 94(4):1440-8. PubMed ID: 7929819
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor-alpha and CD95 ligation suppress erythropoiesis in Fanconi anemia C gene knockout mice.
Otsuki T; Nagakura S; Wang J; Bloom M; Grompe M; Liu JM
J Cell Physiol; 1999 Apr; 179(1):79-86. PubMed ID: 10082135
[TBL] [Abstract][Full Text] [Related]
13. Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells.
Xie Y; de Winter JP; Waisfisz Q; Nieuwint AW; Scheper RJ; Arwert F; Hoatlin ME; Ossenkoppele GJ; Schuurhuis GJ; Joenje H
Br J Haematol; 2000 Dec; 111(4):1057-64. PubMed ID: 11167740
[TBL] [Abstract][Full Text] [Related]
14. Fanconi anaemia genes and susceptibility to cancer.
Mathew CG
Oncogene; 2006 Sep; 25(43):5875-84. PubMed ID: 16998502
[TBL] [Abstract][Full Text] [Related]
15. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
[TBL] [Abstract][Full Text] [Related]
16. Expression of hHR21sp gene by peripheral blood and hematopoietic cells of normal subjects and Fanconi anemia patients.
Deng Y; Li S; Li X; Magali T
Chin Med J (Engl); 2001 Dec; 114(12):1295-9. PubMed ID: 11793857
[TBL] [Abstract][Full Text] [Related]
17. Changes in protein expression due to deleterious mutations in the FA/BRCA pathway.
Salles D; Cabral RE; Pizzatti L; Bisch PM; Paixão JC; de Almeida CE; Seuánez HN; Cabral-Neto JB
Biochem Biophys Res Commun; 2007 Dec; 364(4):755-60. PubMed ID: 17977515
[TBL] [Abstract][Full Text] [Related]
18. Microarray mRNA expression analysis of Fanconi anemia fibroblasts.
Galetzka D; Weis E; Rittner G; Schindler D; Haaf T
Cytogenet Genome Res; 2008; 121(1):10-3. PubMed ID: 18544920
[TBL] [Abstract][Full Text] [Related]
19. Cancer in Fanconi anemia, 1927-2001.
Alter BP
Cancer; 2003 Jan; 97(2):425-40. PubMed ID: 12518367
[TBL] [Abstract][Full Text] [Related]
20. Transduction of CD34-enriched human peripheral and umbilical cord blood progenitors using a retroviral vector with the Fanconi anemia group C gene.
Walsh CE; Mann MM; Emmons RV; Wang S; Liu JM
J Investig Med; 1995 Aug; 43(4):379-85. PubMed ID: 7552587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
